Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials

OBJECTIVES: (1) To assess if co-administration of four-component meningococcal serogroup B vaccine (4CMenB) and other routine vaccines caused an interaction increasing the risk and/or severity of adverse events following immunisation (AEFI) compared with administration at separate visits and (2) to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMJ Open
Main Authors: Zafack, Joseline Guetsop, Bureau, Alexandre, Skowronski, Danuta M, De Serres, Gaston
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2019
Assuntos:
Infectious Diseases
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6530311/
https://ncbi.nlm.nih.gov/pubmed/31110098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-026953
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares